

Genome Editing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The genome editing market is rapidly expanding, driven by advancements in CRISPR technology and rising applications in biotechnology and healthcare. The global market is projected to reach approximately $9.8 billion by 2026, reflecting significant growth opportunities amidst increasing research funding, regulatory support, and rising demand for precision medicine solutions.
◍ Genscript
◍ Horizon Discovery Group
◍ Lonza
◍ Merck KGaA
◍ Sangamo Therapeutics
◍ Thermo Fisher Scientific
The genome editing market features companies like Genscript, Horizon Discovery, Lonza, Merck KGaA, Sangamo Therapeutics, and Thermo Fisher Scientific, which develop CRISPR, TALENs, and ZFNs. Their innovations drive research, therapeutics, and product development, expanding market applications. Notable revenues include Thermo Fisher: $35 billion and Merck KGaA: $27 billion. Request Sample Report
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Request Sample Report
$ 13250.53 Million
Request Sample Report